| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Respiratory Viral and Bacterial Comprehensive Panel by PCR : 11940
Test CodeRCPPCR or 11940
Alias/See Also
Adenovirus, Coronavirus, COVID-19, SARS-CoV-2, Human Metapneumovirus, Influenza A, Influenza B, Parainfluenza Virus, Human Rhinovirus/Enterovirus, Respiratory Syncytial Virus (RSV), Bordetella pertussis, Chlamydophila pneumoniae, Mycoplasma pneumonia, Flu A, Flu B
CPT Codes
0202U
Includes
The 18 viral targets detected are Adenovirus, Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43, SARS-CoV-2, Human Metapneumovirus, Influenza A with subtyping for A/H1, A/H3, and A/H1-2009, Influenza B, Parainfluenza Virus 1, Parainfluenza Virus 2, Parainfluenza Virus 3, Parainfluenza Virus 4, Human Rhinovirus/Enterovirus and Respiratory Syncytial Virus.
The 4 bacterial targets including Bordetella pertussis, Bordetella parapertussis, Chlamydophila pneumoniae and Mycoplasma pneumonia.
The 4 bacterial targets including Bordetella pertussis, Bordetella parapertussis, Chlamydophila pneumoniae and Mycoplasma pneumonia.
Transport Container
One (1) nasopharyngeal swab collected in VCM, UTM or equivalent media.
Specimens can only be collected in physicians’ offices and hospitals. Patient service centers and in-office phlebotomists do not collect respiratory specimens.
Cold packs/pouches should be used if placing specimens in a lockbox for courier pick-up. Each specimen transport vial that is submitted should be accompanied by its own separate requisition and transported in its own sealed bag.
Specimens can only be collected in physicians’ offices and hospitals. Patient service centers and in-office phlebotomists do not collect respiratory specimens.
Cold packs/pouches should be used if placing specimens in a lockbox for courier pick-up. Each specimen transport vial that is submitted should be accompanied by its own separate requisition and transported in its own sealed bag.
Transport Temperature
Refrigerated
Specimen Stability
Room temperature: 4 hours; Refrigerated: 3 days; Frozen: 30 days
Methodology
Qualitative real-time Polymerase Chain Reaction (PCR)
Setup Schedule
Monday - Saturday
Report Available
1 day
Reference Range
NOT DETECTED
Clinical Significance
Respiratory pathogens cause acute local and systemic disease, with severe complications in children, the immunocompromised and the elderly individuals. Symptoms include cough, nasal discharge, congestion, fever, wheezing, headache and myalgia. Due to overlapping symptoms, viral and bacterial respiratory infections are difficult to distinguish clinically. Identification of specific causative agent aids in appropriate patient management, avoid the unnecessary use of antibiotics, and public health response for disease containment.
The test is a FDA-approved FilmArray multiplex real time-PCR platform (BioFire Diagnostics) to simultaneously detect and identify 22 respiratory viral and bacterial pathogens. The assay detects 18 viral targets including Adenovirus, Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43 SARS-CoV-2, Human Metapneumovirus, Influenza A with subtyping for A/H1, A/H3, and A/H1-2009, Influenza B, Parainfluenza Virus 1, Parainfluenza Virus 2, Parainfluenza Virus 3, Parainfluenza Virus 4, Human Rhinovirus/Enterovirus and Respiratory Syncytial Virus and 4 bacterial targets including Bordetella pertussis, Bordetelia parapertussis Chlamydophila pneumoniae and Mycoplasma pneumonia.
This test is preferred for evaluating severely immunocompromised (e.g., BMT) or critically ill (ICU) patients with respiratory symptoms. The test result does not rule out presence of other viruses or bacteria that are not included in this panel. This Test Code is ONLY orderable as a panel. Select targets are available as separate orderable test codes and have to be ordered individually if required such as Bordetella pertussis/parapertussis by PCR (BPPPCR), Mycoplasma pneumoniae by PCR (MPPCR); Influenza A and B by PCR (RFLUAB), Influenza A and B with Flu A/H1N1 typing by PCR (RFLUAT), RSV by PCR (RRSV), Adenovirus Quantitative by PCR (ADVQT) and Enterovirus by PCR (REVPCR).
Test Limitations: Due to the genetic similarity between Rhinovirus and Enterovirus, this test cannot reliably differentiate them. Similarly, the Coronavirus OC43 assay may cross-react with Coronavirus HKU1.
The test is a FDA-approved FilmArray multiplex real time-PCR platform (BioFire Diagnostics) to simultaneously detect and identify 22 respiratory viral and bacterial pathogens. The assay detects 18 viral targets including Adenovirus, Coronavirus 229E, Coronavirus HKU1, Coronavirus NL63, Coronavirus OC43 SARS-CoV-2, Human Metapneumovirus, Influenza A with subtyping for A/H1, A/H3, and A/H1-2009, Influenza B, Parainfluenza Virus 1, Parainfluenza Virus 2, Parainfluenza Virus 3, Parainfluenza Virus 4, Human Rhinovirus/Enterovirus and Respiratory Syncytial Virus and 4 bacterial targets including Bordetella pertussis, Bordetelia parapertussis Chlamydophila pneumoniae and Mycoplasma pneumonia.
This test is preferred for evaluating severely immunocompromised (e.g., BMT) or critically ill (ICU) patients with respiratory symptoms. The test result does not rule out presence of other viruses or bacteria that are not included in this panel. This Test Code is ONLY orderable as a panel. Select targets are available as separate orderable test codes and have to be ordered individually if required such as Bordetella pertussis/parapertussis by PCR (BPPPCR), Mycoplasma pneumoniae by PCR (MPPCR); Influenza A and B by PCR (RFLUAB), Influenza A and B with Flu A/H1N1 typing by PCR (RFLUAT), RSV by PCR (RRSV), Adenovirus Quantitative by PCR (ADVQT) and Enterovirus by PCR (REVPCR).
Test Limitations: Due to the genetic similarity between Rhinovirus and Enterovirus, this test cannot reliably differentiate them. Similarly, the Coronavirus OC43 assay may cross-react with Coronavirus HKU1.
Performing Laboratory
med fusion
